
A review published in the journal Biomimetics by MDPI details how spider silk proteins, called spidroins, could be engineered for biomedical use. Spiders produce different silks for strength or flexibility by adjusting…
A review published in the journal Biomimetics by MDPI details how spider silk proteins, called spidroins, could be engineered for biomedical use. Spiders produce different silks for strength or flexibility by adjusting chemistry during spinning. Scientists are designing silk-based particles and gels to deliver drugs gradually over weeks, and using the material for wound coverings and scaffolds that support tissue repair. Laboratory experiments show engineered silk particles can release small molecules at a steady rate for roughly two weeks. However, these remain experimental, routine medical applications are still distant.
The coverage risks turning a laboratory curiosity into a cure-all. Spider silk is remarkable, but the leap from protein particles that release a drug for two weeks in a dish to a working medicine is vast. Animal trials, manufacturing scale, and human safety data lie ahead. Watch for the first regulatory application for a silk-based drug device, that will separate hype from reality.
Source: timesofindia.indiatimes.com
This story was synthesised by AI from the source linked above.